Aoun et al. associated the BCR development in pT2 prostate cancer with factors such as insufficient diagnosis of surgical margin positivity, limited sections examined even though the entire specimen was sampled, PSA secretion of the postoperative residual benign prostate tissues and occult lymph node metastasis (12). This evidence concerns the gene BCR and prostate carcinoma.